News
09-23-2011, 04:50 AM
Amgen announced today that data from XGEVA (denosumab) and Vectibix (panitumumab) studies will be presented at the 2011 European Multidisciplinary Cancer Congress, Sept. 23 - 27, 2011, in Stockholm, Sweden.
More... (http://www.news-medical.net/news/20110923/Data-from-Amgens-XGEVA-and-Vectibix-studies-to-be-presented-at-EMCC-2011.aspx)
More... (http://www.news-medical.net/news/20110923/Data-from-Amgens-XGEVA-and-Vectibix-studies-to-be-presented-at-EMCC-2011.aspx)